Androgen receptor targeted therapy: Clinical Trials

1 trial of Androgen receptor targeted therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Androgen receptor targeted therapy: new trials by email Literature Review of Androgen receptor targeted therapy trials Research Report on Androgen receptor targeted therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Radiotherapy (SBRT) and/or surgery (metastasectomy), Androgen deprivation therapy, Androgen receptor targeted therapy - Prostate Cancer, Prostate Cancer Recurrent
Phase 3RecruitingUniversitaire Ziekenhuizen KU Leuven8732022-04-202024-07-03

Conditions studied

Neoplasm Metastasis (1)  ·  Prostatic Neoplasms (1)

Sponsors

Universitaire Ziekenhuizen KU Leuven (1)

Countries

Belgium (1)

Results publications

PMID 36503429